SEC Form 4 · accession 0001610717-26-000359
10x Genomics, Inc. · TXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sarah A. Teichmann
Director
Period of report
Aug 13, 2026
Accepted (ET)
Aug 17, 2026 · 4:08 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001770787
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Aug 13, 2026 | S | 5,278 | $57.29 | D | 30,331 | D | |
| Class A Common Stock | Aug 14, 2026 | S | 2,273 | $57.15 | D | 28,058 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 14, 2026.